{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Effects of the Use of Neuromuscular Blocking Agents on Acute Respiratory Distress Syndrome Outcomes: A Systematic Review
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about acute respiratory distress syndrome (ARDS) and best practices for its treatment, with a focus on the use of neuromuscular blocking agents (NMBAs).Learning Objectives
After completing this continuing education activity you will be able to:
- Identify issues related to ARDS, including treatment options.
- Distinguish the use of NMBAs to treat ARDS.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$17.95
Credits:
- AANP 1.5 CH / 1.5 APH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
This Activity is approved for 1.5 contact hour (s) of continuing education (which includes 1.5 hour(s) pharmacology) by the American Association of Nurse Practitioners. Activity ID# 18043162
This Activity was planned in accordance with AANP Accreditation Standards and Policies.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JAANP0618
Published: Jun 2018
Expires: 12/31/2026
Required Passing Score: 1/18 (5%)